Bmesalamine Delayed-release Tablets, Usp 1.2g Ndc 62135-714-12 (120 Tablets label)
Mesalamine Tablet, Delayed Release
Product Images NDC 62135-714
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 62135-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mesalamine Delayed-release Tablets, Usp 1.2g Ndc 62135-714-60 (60 Tablets label)
Description: This is a medication label for Mesalamine delayed-release tablets. Each tablet contains 1.2 g of Mesalamine. It is meant to be taken once daily and requires a prescription. The label indicates that there are 60 tablets in the package. The brand name or manufacturer is Chartwell Rx. Please keep this medication out of reach of children.*
Image Description (Mesalamine Dr Tablets Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
